No not at all Dufrane, I didn’t think you were having a go. The reason I was in two minds about how to answer was because of stocks like UNS where I saw many great people hold it all the way to the bottom and really destroy their wealth. I held it but always traded it and was honest and open about that, though that’s not what a lot of investors do so when talking of this company I wanted to let you know my intentions and not just talk it up.
I do really think there is a great chance of success here but it is early days, that’s why I’m here and will be keeping a very close eye on the company, management, partners and the science. The first clinical license partner will be rather telling for me and the details surrounding it, I like the fact that these guys should be able to go through the steps needed without continually tapping shareholders also.
They’re in the right country to make a success of this and with the right partners it makes it all the more possible to achieve set targets/outcomes, especially in the bio/life sciences sectors, seen way too many good asx companies never make it due to lack of expertise at the top or lack of funding/license partners to get it things through.
GL in your decision, oh and that AS bloke deserves what ever bad karma has coming his way!
RGS Price at posting:
12.5¢ Sentiment: Buy Disclosure: Held
